Chinese e-commerce giant Alibaba Group Holding Ltd. (NYSE:BABA), which launched a headline-grabbing $25 billion IPO last month, has obviously had an easy time raising money in the U.S., but it had a tougher go of it this week registering one. On last trading day Alibaba Group Holding Ltd (NYSE:BABA) moved down -3.28% to close at $85.88. Its volatility for the week is 2.65%.Analysts at Goldman Sachs, in a September 23 note to clients titled "Small Caps: In Search of Stability Among the Volatility," focus on three themes: companies with strong free cash flow, companies with rising earnings estimates and companies on the cusp of a new product cycle. Goldman cites Lumenis Ltd. (NASDAQ:LMNS ) as an example of a company with a slumping stock in the face of an appealing product cycle launch. The medical device manufacturer "is in the very early stages of a multi-year cycle of new product introductions," note the analysts, who see nearly 100% upside to their $17 price target. On last trading day Lumenis Ltd. (NASDAQ:LMNS) moved up 0.33% to close at $9.03. Its volatility for the week is 1.73% while volatility for the month is 2.74%. LMNS's sales growth for past 5 years was 0.70% and its EPS growth for past 5 years was 32.80%. Lumenis Ltd. (NASDAQ:LMNS) monthly performance is 2.73%.The Deal, TheStreet’s (NASDAQ:TST) institutional business, has issued a quarterly report that shows that 275 private-investments-in-public-equity (PIPEs) worth $11.4 billion were announced or completed in the third quarter, compared with 267 that raised $10.2 billion in the same period a year ago. TheStreet, Inc. (NASDAQ:TST) has 0.20% insider ownership while its institutional ownership stands at 64.10%. In last trading activity company's stock closed at $2.25.GenMark Diagnostics (NASDAQ:GNMK) CEO Hany Massarany unloaded 3,795 shares of the stock on the open market in a transaction dated Friday, September 5th. The stock was sold at an average price of $10.04, for a total transaction of $38,101.80. Following the completion of the sale , the chief executive officer now directly owns 167,662 shares of the company’s stock, valued at approximately $1,683,326. On Friday shares of GenMark Diagnostics, Inc. (NASDAQ:GNMK) closed at $9.08. Company's sales growth for last 5 years was 114.70% and EPS growth for next 5 years is recorded as 30.00%.Novavax, Inc. (NASDAQ:NVAX) on Sept. 23 announced that it has executed a contract modification with the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA) to exercise the option period of its current contract (HHSO100201100012C) for the advanced development of Novavax’ recombinant seasonal and pandemic influenza vaccines and manufacturing capabilities for pandemic preparedness. Novavax, Inc. (NASDAQ:NVAX) in last trading activity moved down -0.23% to close at $4.40. Company weekly performance is 7.06% while its quarterly performance stands at -2.00%. Novavax, Inc. (NASDAQ:NVAX) is -36.69% away from its 52 week high.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
